CapsuleTech Partners with Masimo to Integrate Masimo SET® Pulse Oximetry Technology into SmartLinx Vitals Plus® Patient Monitoring System
ANDOVER, Mass. and IRVINE, Calif., April 14, 2015 /PRNewswire/ -- CapsuleTech, the global leader in medical device integration, and Masimo, the recognized industry leader in Pulse Oximetry and Pulse Co-Oximetry, jointly announce the integration of Masimo SET® Measure-through Motion and Low Perfusion™ pulse oximetry technology into the upcoming SmartLinx Vitals Plus® Patient Monitoring System.
SmartLinx Vitals Plus® adds vital signs monitoring capabilities to the Capsule SmartLinx Medical Device Information System™ (MDIS), creating an integrated platform of products designed to increase efficiency and help improve patient care delivery through the systematic capture of patient vital signs at the point-of-care, and the delivery of captured data to hospital electronic medical records, other information systems and 3rd party mobile solutions.
Vitals Plus offers healthcare organizations an innovative, all-in-one solution for monitoring and clinical documentation. Leveraging the power and utility of Capsule's SmartLinx Neuron®2 mobile clinical computer and the clinical accuracy of Masimo SET® technology, clinicians using Vitals Plus will now be able to display oxygenation, pulse rate and perfusion index values at point-of-care, supporting clinicians with patient assessments, intervention and treatment, in parallel with delivering the validated vital signs directly to the medical record.
Masimo SET® Measure-through Motion and Low Perfusion™ pulse oximetry technology helps clinicians monitor more than 100 million patients a year and is the primary pulse oximetry technology for eight of the top 10 hospitals on the U.S. News & World Report Best Hospitals Honor Roll for 2014-15. Utilizing patented signal processing technologies, including Parallel Engines, adaptive filters, Discrete Saturation Transform, and Fast Saturation Transform, Masimo SET® delivers accurate and reliable measurements of a patient's oxygenation status when conventional pulse oximetry technologies don't—reducing false alarms by over 95% and expanding true alarm detection to over 97%.1,2
"The integration of Masimo SET with SmartLinx Vitals Plus will provide caregivers the ability to more accurately measure a patients' oxygenation, even during challenging conditions of patient motion and low perfusion," said Gene Cattarina, Capsule CEO. "With Vitals Plus, we have a product in a class of its own with its clinician-friendly workflow and cost-effective design that enables hospitals to move from charting to monitoring all with the same Neuron 2."
Masimo's President of Worldwide OEM Business & Blood Management, Rick Fishel stated, "We're proud of the positive impact our respective technologies have on patient care, safety, and clinical outcomes. Combining innovative solutions to improve patient outcomes, optimize workflow, increase patient throughput, and reduce the cost of healthcare is a shared vision between our organizations. We are very pleased that Masimo SET pulse oximetry platform is a key component in SmartLinx Vitals Plus, and we look forward to our future contributions to this innovative product."
About Capsule
CapsuleTech is the leading global provider of medical device integration solutions for hospitals and healthcare organizations. Capsule's solutions unlock the power of medical device data through connectivity, advanced integration and analytics that turn volumes of data into actionable patient and device information to drive informed clinical and operational decisions. The Company was recently named category leader for medical device integration systems, according to the annual "2014 Best in KLAS Awards: Software & Services" report, published in January. Founded in 1997, the Company has established strong partnerships with leading medical device manufacturers and installed enterprise-wide solutions in over 1,800 hospitals in 38 countries. For more information, visit www.capsuletech.com or call +1 978-482-2337 (US), or +33 1 84 17 12 00 (France).
About Masimo
Masimo (NASDAQ: MASI) is the global leader in innovative noninvasive monitoring technologies that significantly improve patient care-helping solve "unsolvable" problems. In 1995, the company debuted Measure-Through Motion and Low Perfusion pulse oximetry, known as Masimo SET®, which virtually eliminated false alarms and increased pulse oximetry's ability to detect life-threatening events. More than 100 independent and objective studies have shown that Masimo SET® outperforms other pulse oximetry technologies, even under the most challenging clinical conditions, including patient motion and low peripheral perfusion. In 2005, Masimo introduced rainbow SET® Pulse CO-Oximetry technology, allowing noninvasive and continuous monitoring of blood constituents that previously could only be measured invasively, including total hemoglobin (SpHb®), oxygen content (SpOC™), carboxyhemoglobin (SpCO®), methemoglobin (SpMet®), and Pleth Variability Index (PVI®), in addition to SpO2, pulse rate, and perfusion index (PI). Additional information about Masimo and its products may be found at www.masimo.com. @masimoinnovates
1 Shah N, Ragaswamy HB, Govindugari K, Estanol L "Performance of Three New-Generation Pulse Oximeters during Motion and Low Perfusion in Volunteers" .J Clin Anesth. 2012 Aug;24(5):385-91.
2 Taenzer, Andreas H.; Pyke, Joshua B.; McGrath, Susan P.; Blike, George T. "Impact of Pulse Oximetry Surveillance on Rescue Events and Intensive Care Unit Transfers: A Before-and-After Concurrence Study." Anesthesiology, February 2010, Vol. 112, Issue 2.
Connect with Capsule:
Capsule's corporate blog http://blog.capsuletech.com/
SOURCE CapsuleTech
Share this article